Acasti Pharma Reports First Quarter 2023 Operational Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- Wall St climbs as Mideast tensions ease, Comcast surges on spin-off plan
- Tech funds suffer record outflows as investors trim equity positions
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- SpaceX weighs Starlink mobile service to US consumers, FT reports
Acasti Pharma (ACST) Reports Q2 Loss of $0.10
August 11, 2022 7:10 AM EDTAcasti Pharma (NASDAQ: ACST) reported Q2 EPS of ($0.10).
For earnings history and earnings-related data on Acasti Pharma (ACST) click here.
... More